Prestige Consumer Healthcare (PBH) Net Cash Flow (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Net Cash Flow of -$57.0 million for Q4 2025, down 4142.91% year-over-year from $1.4 million in Q4 2024, and down 179.55% quarter-over-quarter from -$20.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Net Cash Flow (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Net Cash Flow history runs 16 years deep, the most recent figure standing at -$57.0 million for Q4 2025.
- In Q4 2025, Net Cash Flow fell 4142.91% year-over-year to -$57.0 million; the TTM figure through Dec 2025 stood at $10.3 million (up 189.88% YoY), while the FY2025 annual figure was $52.0 million, up 526.13% from the prior year.
- Net Cash Flow for Q4 2025 stood at -$57.0 million, down from -$20.4 million in the prior quarter.
- The five-year high for Net Cash Flow was $131.6 million in Q2 2021, with the low at -$119.9 million in Q3 2021.
- The 5-year median for Net Cash Flow is $1.8 million (2023), against an average of $89700.0.
- The sharpest annual moves came in 2021 and 2025: Net Cash Flow surged 439.6% in 2021, then sank 4142.91% in 2025.
- Prestige Consumer Healthcare's Net Cash Flow stood at -$21.6 million in 2021, then jumped by 299.9% to $43.1 million in 2022, then sank by 95.05% to $2.1 million in 2023, then tumbled by 33.9% to $1.4 million in 2024, then tumbled by 4142.91% to -$57.0 million in 2025.
- Business Quant data shows PBH's Net Cash Flow at -$57.0 million in Q4 2025, -$20.4 million in Q3 2025, and $40.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -57.01 Mn |
| Dec 31, 2025 | -57.01 Mn |
| Sep 30, 2025 | -20.39 Mn |
| Sep 30, 2025 | -20.39 Mn |
| Jun 30, 2025 | 40.79 Mn |
| Jun 30, 2025 | 40.79 Mn |
| Mar 31, 2025 | 46.88 Mn |
| Mar 31, 2025 | 46.88 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 16.57 Mn |
| Sep 30, 2024 | 16.57 Mn |
| Jun 30, 2024 | -12.88 Mn |
| Jun 30, 2024 | -12.88 Mn |
| Mar 31, 2024 | -16.54 Mn |
| Mar 31, 2024 | -16.54 Mn |
| Dec 31, 2023 | 2.13 Mn |
| Dec 31, 2023 | 2.13 Mn |
| Sep 30, 2023 | 5.98 Mn |
| Sep 30, 2023 | 5.98 Mn |